Abstract
Background and Objectives Preterm infants (<34 weeks’ gestation) experience high rates of morbidity and mortality before hospital discharge. Genetic disorders substantially contribute to morbidity and mortality in related populations. The prevalence and clinical impact of genetic disorders is unknown in this population. We sought to determine the prevalence of commonly diagnosed genetic disorders in preterm infants, and to determine the association of disorders with morbidity and mortality.
Methods This was a retrospective multicenter cohort study of infants born from 23 to 33 weeks’ gestation between 2000 and 2020. Genetic disorders were abstracted from diagnoses present in electronic health records. We excluded infants transferred from or to other health care facilities prior to discharge or death when analyzing clinical outcomes. We determined the adjusted odds of pre-discharge morbidity or mortality after adjusting for known risk factors.
Results Of 320,582 infants, 4196 (1.3%) had genetic disorders. Infants with trisomy 13, 18, 21, or cystic fibrosis had greater adjusted odds of severe morbidity or mortality. Of the 17,427 infants who died, 566 (3.2%) had genetic disorders. Of the 65,968 infants with a severe morbidity, 1319 (2.0%) had genetic disorders.
Conclusions
Genetic disorders are prevalent in preterm infants, especially those with life-threatening morbidities. Clinicians should consider genetic testing for preterm infants with severe morbidity and maintain a higher index of suspicion for life-threatening morbidities in preterm infants with genetic disorders. Prospective genomic research is needed to clarify the prevalence of genetic disorders in this population, and the contribution of genetic disorders to preterm birth and subsequent morbidity and mortality.
Article Summary Genetic disorders were found in 1.3% of preterm infants and at a higher rate (2.0%) in infants who died or developed severe morbidity.
What’s Known on This Subject Previous research described the prevalence and associated short-term morbidity and mortality of trisomy 13, 18, and 21 in preterm infants. The prevalence of other commonly diagnosed genetic disorders and associated short-term morbidity and mortality in preterm infants is unknown.
What This Study Adds In a multicenter, retrospective cohort of 320,582 preterm (<34 weeks’ gestation) infants, we found that 1.3% had genetic disorders diagnosed through standard care. Multiple disorders were associated with increased adjusted odds of morbidities or mortality prior to hospital discharge.
Contributors Statement Page Selin S. Everett conceptualized and designed the study, conducted analyses, drafted the initial manuscript, and critically reviewed and revised the manuscript.
Dr. Thomas Hays conceptualized and designed the study, drafted the initial manuscript, and critically reviewed and revised the manuscript.
Miles Bomback conceptualized and designed the study and critically reviewed and revised the manuscript.
Drs. Veeral N. Tolia and Reese H. Clark coordinated and supervised data collection and critically reviewed and revised the manuscript.
Dr. Rakesh Sahni conceptualized and designed the study and critically reviewed and revised the manuscript.
Dr. Alex Lyford conducted analyses and critically reviewed and revised the manuscript. Dr. Ronald J. Wapner reviewed and critically revised the manuscript.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Author TH is supported by two career development awards: the Thrasher Research Fund Early Career Award and the NIH National Center for Advancing Translational Sciences (KL2TR001874).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the institutional review board of Columbia University with a waiver for informed consent (IRB Protocol #AAAT2607).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Conflict of Interest Disclosures (includes financial disclosures): The authors have no example conflicts of interest to disclose.
Funding/Support: No funding was secured for this study. TH is supported by a Thrasher Research Fund Early Career Award.
Role of Funder/Sponsor (if any): The Thrasher Research Fund had no role in the design and conduct of the study.
Abbreviations: AKI (acute kidney injury), BPD (bronchopulmonary dysplasia), ICH (intracerebral hemorrhage), OR (odds ratio) NEC (necrotizing enterocolitis), ROP (retinopathy of prematurity)
We have made 2 major changes to this manuscript: we added a figure showing prevalence of genetic disorders over time; we simplified analyses of prevalence and outcomes to use the same denominator to avoid confusion. We also made minor formatting and wording changes.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
